Список литературы

1. Голдсмит Л.А., Кац С.И., Джилкрест Б.А. и др.; пер. С англ.; общ. ред. Потекаева Н.Н., Львова А.Н. – изд. 2-е, Издательство Панфилова, 2015 – Дерматология Фицпатрика в клинической практике – Т. 1, стр. 167-181. 24 2. Martin SF, Rustemeyer T, Thyssen JP. Recent advances in understanding and managing contact dermatitis. F1000Res. 2018 Jun 20;7. pii: F1000 Faculty Rev-810.doi: 10.12688/f1000research.13499.1. e Collection 2018. Review. PubMed PMID:29983912; PubMed Central PMCID: PMC6013761. 3. Litchman G, Nair PA, Atwater AR, Gossman WG. Contact Dermatitis. 2019 Jul 28. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK459230/PubMed PMID: 29083649. 4. О.Л. Иванов, А.Н. Львов, Феденко Е.С.,Т.А. Белоусова, С.С. Землякова. Аллергический контактный дерматит: механизмы формирования и принципы диагностики. Учебнометодическое пособие для студентов. – М.: «Издательский дом «Русский врач», 2010. 5. Федеральные клинические рекомендации. Аллергический Контактный Дерматит. Феденко Е.С., Елисютина О.Г. // Российский аллергологический журнал. 2016. № 6. С. 52- 57. 6. Bingham LJ, Tam MM, Palmer AM, Cahill JL, Nixon RL. Contact allergy and allergic contact dermatitis caused by lavender: A retrospective study from an Australian clinic. // Contact Derm. 2019 Jul;81(1):37-42. 7. Kimyon RS, Warshaw EM. Airborne Allergic Contact Dermatitis: Management and Responsible Allergens on the American Contact Dermatitis Society Core Series. // Dermatitis. 2019 Mar/Apr; 30(2):106-115. 8. Thyssen JP, Linneberg A, Menné T, et al. : The epidemiology of contact allergy in the general population-prevalence and main findings. Contact Dermatitis. 2007; 57(5):287–99. 9. Williams JD, Lee AY, Matheson MC, Frowen KE, Noonan AM, Nixon RL. Occupational contact urticaria: Australian data. Br J Dermatol. 2008 Jul;159(1):125-31. 10. Статистический сборник. Ресурсы и деятельность медицинских организаций дерматовенерологического профиля. заболеваемость инфекциями, передаваемыми половым путем, заразными кожными болезнями и заболеваниями кожи за 2017-2018 годы (статистические материалы). РИО: ФГБУ «ЦНИИОИЗ» Минздрава России. Москва. 29019. 208 с. 11. Статистический сборник. Ресурсы и деятельность медицинских организаций дерматовенерологического профиля. заболеваемость инфекциями, передаваемыми половым путем, заразными кожными болезнями и заболеваниями кожи за 2014-2015 годы (статистические материалы). РИО: ФГБУ «ЦНИИОИЗ» Минздрава России. Москва. 29019. 208 с. 25 12. Johnston GA, Exton LS, MohdMustapa MF, Slack JA, Coulson IH, English JS, Bourke JF. British Association of Dermatologists' guidelines for the management of contact dermatitis 2017. // Br J Dermatol. 2017 Feb;176(2):317-329. 13. Потекаев Н.Н., Акимов В.Г. Дифференциальная диагностика и лечение кожных болезней - М.: ГЭОТАР – Медиа, 2016. - 182 стр. 14. Owen JL, Vakharia PP, Silverberg JI. The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis. // Am J Clin Dermatol. 2018 Jun;19(3):293-302. 15. Johansen JD, Aalto-Korte K, Agner T, et al. : European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. // Contact Dermatitis. 2015;73(4):195–221. 16. Stingeni L, Bianchi L, Hansel K, Corazza M, Gallo R, Guarneri F, Patruno C, Rigano L, Romita P, Pigatto PD, Calzavara-Pinton P., "Skin Allergy" group of SIDeMaST and "SIDAPA" (SocietàItaliana di DermatologiaAllergologica, Professionale e Ambientale). Italian Guidelines in Patch Testing - adapted from the European Society of Contact Dermatitis (ESCD). // G Ital Dermatol Venereol. 2019 Jun;154(3):227-253. 17. DeKoven JG, Warshaw EM, Zug KA, Maibach HI, Belsito DV, Sasseville D, Taylor JS, Fowler JF, Mathias CGT, Marks JG, Pratt MD, Zirwas MJ, DeLeo VA. North American Contact Dermatitis Group Patch Test Results: 2015-2016. // Dermatitis. 2018 Nov/Dec;29(6): 297-309. 18. Uter W, Bruze M, Rustemeyer T, et al. : Re "International survey on skin patch test procedures, attitudes and interpretation" L.K. Tanno et al., WAOJ (2016) 9:8. World Allergy Organ J. 2017;10(1):18. 10.1186/s40413-017-0149-0 19. Engfeldt M, Hagvall L, Isaksson M, et al. : Patch testing with hydroxyisohexyl 3- cyclohexene carboxaldehyde (HICC) - a multicentre study of the Swedish Contact Dermatitis Research Group. // Contact Dermatitis. 2017; 76(1):34–9. 10.1111/cod.12699 20. Uter W, Bruze M, Rustemeyer T, et al. : Re "International survey on skin patch test procedures, attitudes and interpretation" L.K. Tanno et al., WAOJ (2016) 9:8. World Allergy Organ J. 2017;10(1):18. 10.1186/s40413-017-0149-0 21. Bennike NH, Palangi L, Christensson JB, Nilsson U, Zachariae C, Johansen JD,Hagvall L. Allergic contact dermatitis caused by hydroperoxides of limonene and dose-response relationship-A repeated open application test (ROAT) study. Contact Dermatitis. 2019 Apr; 80(4):208-216. 22. Marks JG, Belsito DV, DeLeo VA, Fowler JF Jr, Fransway AF, Maibach HI, et al. North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. // J Am Acad Dermatol 1998; 38 (Pt 1): 911-8 (III). 26 23. Marks JG Jr, Belsito DV, DeLeo VA, Fowler JF Jr, Fransway AF, Maibach HI, et al. North American Contact Dermatitis Group patch-test results, 1998 to 2000. // Am J Contact Dermat 2003;14:59-62 (III). 24. Pratt MD, Belsito DV, DeLeo VA, Fowler JF Jr, Fransway AF, Maibach HI, et al. North American Contact Dermatitis Group patch-test results, 2001-2002 study period. // Dermatitis 2004;15:176-83 (III). 25. Lee TY, Lam TH. Patch testing of 490 patients in Hong Kong. // Contact Dermatitis 1996; 35:23-6 (III). 26. Warshaw EM, Belsito DV, Taylor JS, Sasseville D, Dekoven JG, Zirwas MJ, et al. North American Contact Dermatitis Group Patch Test Results: 2009 to 2010. // Dermatitis 2013;24:50- 9 (III). 27. Fonacier L, Bernstein DI, Pacheco K, Holness DL, Blessing-Moore J, Khan D,Lang D, Nicklas R, Oppenheimer J, Portnoy J, Randolph C, Schuller D, Spector S, Tilles S, Wallace D; American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma &Immunology; Joint Council of Allergy, Asthma & Immunology. Contact dermatitis: a practice parameter-update 2015. // J Allergy Clin Immunol Pract. 2015 May-Jun;3(3 Suppl):S1-39. doi: 10.1016/j.jaip.2015.02.009. PubMed PMID: 25965350. 28. Rodriguez-Homs LG, Taylor J, Liu B, Green CL, Brod B, Jacob SE, Sheehan M,Dunnick CA, Atwater AR. Patch Test Practice Patterns of Members of the American Contact Dermatitis Society. // Dermatitis. 2019 Oct 11. doi: 10.1097/DER.0000000000000513. [Epub ahead of print] PubMed PMID: 31609854. 29. Cohen DE, Heidary N. Treatment of irritant and allergic contact dermatitis. // Dermatol Ther. 2004;17(4):334–40. 30. Лусс Л. В. Современные проблемы диагностики и терапии аллергического контактного дерматита // Доктор. Ру. 2009. No 2 (46). С. 63–67. 31. Yasuda T. Clinical experiences with hydrocortisone 17-butyrate. Dermatologica 1976; 152 (suppl.1):221-229. 32. Перламутров Ю. Н., Ольховская К. Б. и др. Результаты всероссийского многоцентрового открытого наблюда- тельного исследования «АККОРД» по определению эф- фективности, безопасности и переносимости различных форм Адвантана при лечении больных контактными де- рматитами // Клин. дерматол. и венерол. — 2009. — Т. 4.—С.72–79. 33. Jean-Marie Lachapelle, Ana Gimenez-Arnau, Martin Metz, Jill Peters & Ehrhardt Proksch (2017): Best Practices, New Perspectives and The Perfect Emollient: 27 Optimizing the Management of Contact Dermatitis, Journal of Dermatological Treatment, DOI: 10.1080/09546634.2017.1370074 34. Матушевская, Е. В., И. Г. Шакуров, З. Р. Хисматуллина. "Эффективность и переносимость препаратов линии акридерм в практике дерматовенеролога." Клиническая дерматология и венерология 2 (2008): 32-37. 35. Ramsing DW, Agner T: Efficacy of topical corticosteroids on irritant skin reactions. // Contact Dermatitis 1995;32:293–297. 36. Круглова Л.С., Жукова О.В. Преимущества применения 0,05% бетаметазона дипропионата в форме спрея при лечении контактного и аллергического дерматитов. Клиническая дерматология и венерология. 2016. Т. 15. № 5. С. 25-31. DOI: 10.17116/klinderma201615525-31 37. Veien NK, Olholm Larsen P, Thestrup-Pedersen K, Schou G. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. // Br J Dermatol. 1999 May; 140(5):882-6. 38. Schuttelaar M.L.A., Oosterhaven J.A.F., Christoffers W.A., Romeijn G.L.E., Voorberg A.N. (2019) Evidence-Based Management of Hand Eczema. In: John S., Johansen J., Rustemeyer T., Elsner P., Maibach H. (eds) Kanerva’s Occupational Dermatology. Springer, Cham 39. Levin C, Zhai H, Bashir S, et al. Efficacy of corticosteroids in acute experimental irritant contact dermatitis. Skin Res Technol 2001: 7: 214–218. 40. Levin C, Maibach HI. An overview of the efficacy of topical corticosteroids in experimental human nickel contact dermatitis. // Contact Dermatitis 2000; 43: 317–21 41. Tromovitch TA, Jacobs PH, Puzak HP. Triamcinolone and Hydrocortisone in Topical Therapy. Arch Dermatol. 1963;87(1):35–36. 42. Quielle-Roussel C, Duteil L, Padilla JM, Poncet M, Czernielewski J. Objective assessment of topical anti-inflammatory drug activity on experimentally induced nickel contact dermatitis: comparison between visual scoring, colorimetry, laser Doppler velocimetry and transepidermal water loss. Skin Pharmacol 1990;3:248-55. 43. Hachem JP, De Paepe K, Vanpée E, Kaufman L, Rogiers V, Roseeuw D. Combination therapy improves the recovery of the skin barrier function: an experimental model using a contact allergy patch test combined with TEWL measurements. // Dermatology. 2001;202(4):314-9. 44.Hachem JP, De Paepe K, Vanpée E, Bogaerts M, Kaufman L, Rogiers V, Roseeuw D. Efficacy of topical corticosteroids in nickel-induced contact allergy. // ClinExp Dermatol. 2002 Jan;27(1):47-50. 28 45. Möller H, Svartholm H, Dahl G. Intermittent maintenance therapy in chronic hand eczema with clobetasol propionate and flupredniden acetate. Curr Med Res Opin. 1983;8(9):640‐644. doi:10.1185/03007998309109812 46.Parneix-Spake A, Goustas P, Green R. Eumovate (clobetasone butyrate) 0.05% cream with its moisturizing emollient base has better healing properties than hydrocortisone 1% cream: a study in nickel-induced contact dermatitis. // J Dermatolog Treat. 2001 Dec;12(4):191-7. 47. Vernon HJ, Olsen EA. A controlled trial of clobetasol propionate ointment 0.05% in the treatment of experimentally induced Rhus dermatitis. // J Am Acad Dermatol. 1990 Nov; 23 (5 Pt 1) : 829-32. 48. Saripalli YV, Gadzia J, Belsito D. Tacrolimus ointment 0.1% in the treatment of nickelinduced allergic contact dermatitis. Journal of the American Academy of Dermatology 2003: 49: 477– 482. 49. Han JS, Won KH, Chang SE, Kim JE. Tacrolimus 0.1% ointment in the treatment of allergic contact dermatitis: a new approach. // Int J Dermatol. 2014 Oct; 53 (10) :e470-1. 50. Belsito D, Wilson DC, Warshaw E et al. A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis. // J Am Acad Dermatol 2006; 55:40–6. 51. Katsarou A, Makris M, Papagiannaki K, Lagogianni E, Tagka A, Kalogeromitros D. Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study. // Eur J Dermatol. 2012 Mar-Apr;22(2):192-6. 52. Belsito DV, Fowler JF Jr, Marks JG Jr, et al. Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis. 2004;73(1):31‐38. 53. Helm T, William J. Allergic Contact Dermatitis. Medscape Article. 2019 Feb; https://emedicine.medscape.com/article/1049216-overview 54. Матушевская Е.В., Свирщевская Е.В. Антигистаминные препараты в дерматологии. // Клиническая дерматология и венерология. 2018. Т. 17. № 1. С. 14-21. 55. Curtis G, Lewis AC. Treatment of severe poison ivy: a randomized, controlled trial of long versus short course oral prednisone. // J Clin Med Res. 2014 Dec; 6(6):429-34. 56. Anveden I, Lindberg M, Andersen K E et al. Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis2004: 50: 298–303. 57. Cher-Han Tan, Sarah Rasool, Graham A. Johnston, Contact dermatitis: Allergic and irritant, Clinics in Dermatology, Volume 32, Issue 1, 2014, Pages 116-124, ISSN 0738-081X, https://doi.org/10.1016/j.clindermatol.2013.05.033. 29 58. Diepgen, Thomas L., et al. "Guideline on the management of hand eczema ICD‐10 Code: L20. L23. L24. L25. L30." JDDG: Journal der Deutschen Dermatologischen Gesellschaft 7 (2009): S1-S15. 59. Hjorth N, Schmidt H, Thomsen K. Fusidic acid plus betamethasone in infected or potentially infected eczema. Pharmatherapeutica 1985; 4: 126– 31. 60. Va Hill, E Wong, Mf Corbett & Ap Menday (1998) Comparative efficacy of betamethasone/clioquinol (Betnovate-C) cream and betamethasone/fusidic acid (Fucibet) cream in the treatment of infected hand eczema, Journal of Dermatological Treatment, 9:1, 15- 19, DOI: 10.3109/09546639809160683 61. Network of Dermatological Clinics (IVDK), the German Society for Allergology and Clinical Immunology (DGAKI), the Working Group for Occupational and Environmental Dermatology (ABD) of the DDG, the Medical Association of German Allergologists(AeDA), the Professional Association of German Dermatologists (BVDD) and the DDG. // Allergo J Int. 2014;23(4):126-138. 62. Berndt U., Wigger-Alberti W., Gabard B., Elsner P. Efficacy of a barrier cream and its vehicle as protective measures against occupational irritant contact dermatitis. Contact Dermatitis 2000; 42: 77–80. 63. Rosén K, Mobacken H, Swanbeck G. Chronic eczematous dermatitis of the hands: a comparison of PUVA and UVB treatment. Acta DermVenereol. 1987;67(1): 48-54. 64. Brasch J, Becker D, Aberer W, Bircher A, Kränke B, Jung K, Przybilla B,Biedermann T, Werfel T, John SM, Elsner P, Diepgen T, Trautmann A, Merk HF, FuchsT, Schnuch A. Guideline contact dermatitis: S1-Guidelines of the German Contact Allergy Group (DKG) of the German Dermatology Society (DDG), the Information. 65. Brass D, Fouweather T, Stocken DD, Macdonald C, Wilkinson J, Lloyd J, Farr PM, Reynolds NJ, Hampton PJ. An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema. Br J Dermatol. 2018 Jul;179 (1):63-71. 66. Федеральные клинические рекомендации. Дерматовенерология 2015. Болезни кожи. Инфекции, передаваемые половым путем / Москва, 2016. (5-е издание, переработанное и дополненное). 67. Antico A, Soana R. Chronic allergic-like dermatopathies in nickel-sensitive patients. Results of dietary restrictions and challenge with nickel salts. Allergy Asthma Proc 1999; 20: 235–42 68. Erdmann SM, Werfel T. Hematogenous contact eczema induced by foods. Hautarzt 2006; 57: 116–20 30 69. Ramsing D.W., Agnew T. Effect of gloves occlusion on human skin (II). Long-term experimental exposure. Contact Dermatitis. 1996; 91: 1140–1145. 70. Fregert S. Manual of Contact Dermatitis on Behalf of the International Contact Dermatitis Research Group and the North American Contact Dermatitis Group, 2nd edn. Copenhagen: Munksgaard Publishers, 1981. 71. А.Н. Львов, Е.С. Феденко, О.Л. Иванов, Т.А. Белоусова, С.С. Полунина. Возможности и перспективы диагностики аллергического контактного дерматита в современной практике // Российский аллергологический журнал. 2008. - №1. - С.49-55. 31